Stock Track | Teladoc Health Soars 5.12% on Q3 Revenue Beat and Positive Analyst Outlook

Stock Track

Oct 24

Teladoc Health Inc. (TDOC) shares are soaring 5.12% in pre-market trading on Friday, following the company's announcement of better-than-expected preliminary third-quarter revenue and reaffirmed full-year guidance. The telehealth provider reported preliminary Q3 revenue of $626.4 million, surpassing analysts' estimates of $625.9 million.

Despite the announced departure of Chief Financial Officer Mala Murthy, effective November 21, investors seem to be focusing on the company's strong financial performance. Teladoc also reiterated its 2025 revenue forecast range of $2.50 billion to $2.55 billion, in line with analyst expectations of $2.52 billion.

The positive sentiment is further bolstered by analyst actions. Bank of America raised its price target on Teladoc to $9 from $8.50, while maintaining a Neutral rating. Canaccord Genuity analyst Richard Close reiterated a Buy rating with a $12 price target, citing the company's potential for growth. These developments suggest that despite leadership changes, Teladoc's business fundamentals remain strong, driving investor confidence and the stock's upward movement.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1148412481"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1148412481\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1148412481?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-24 22:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1148412481","market":"sg","top_or_hot":-1,"title":"Stock Track | Teladoc Health Soars 5.12% on Q3 Revenue Beat and Positive Analyst Outlook","media":"Stock Track","content":"<p>Teladoc Health Inc. (TDOC) shares are soaring 5.12% in pre-market trading on Friday, following the company's announcement of better-than-expected preliminary third-quarter revenue and reaffirmed full-year guidance. The telehealth provider reported preliminary Q3 revenue of $626.4 million, surpassing analysts' estimates of $625.9 million.</p>\n\n<p>Despite the announced departure of Chief Financial Officer Mala Murthy, effective November 21, investors seem to be focusing on the company's strong financial performance. Teladoc also reiterated its 2025 revenue forecast range of $2.50 billion to $2.55 billion, in line with analyst expectations of $2.52 billion.</p>\n\n<p>The positive sentiment is further bolstered by analyst actions. Bank of America raised its price target on Teladoc to $9 from $8.50, while maintaining a Neutral rating. Canaccord Genuity analyst Richard Close reiterated a Buy rating with a $12 price target, citing the company's potential for growth. These developments suggest that despite leadership changes, Teladoc's business fundamentals remain strong, driving investor confidence and the stock's upward movement.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Teladoc Health Soars 5.12% on Q3 Revenue Beat and Positive Analyst Outlook</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Teladoc Health Soars 5.12% on Q3 Revenue Beat and Positive Analyst Outlook\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-10-24 22:08</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Teladoc Health Inc. (TDOC) shares are soaring 5.12% in pre-market trading on Friday, following the company's announcement of better-than-expected preliminary third-quarter revenue and reaffirmed full-year guidance. The telehealth provider reported preliminary Q3 revenue of $626.4 million, surpassing analysts' estimates of $625.9 million.</p>\n\n<p>Despite the announced departure of Chief Financial Officer Mala Murthy, effective November 21, investors seem to be focusing on the company's strong financial performance. Teladoc also reiterated its 2025 revenue forecast range of $2.50 billion to $2.55 billion, in line with analyst expectations of $2.52 billion.</p>\n\n<p>The positive sentiment is further bolstered by analyst actions. Bank of America raised its price target on Teladoc to $9 from $8.50, while maintaining a Neutral rating. Canaccord Genuity analyst Richard Close reiterated a Buy rating with a $12 price target, citing the company's potential for growth. These developments suggest that despite leadership changes, Teladoc's business fundamentals remain strong, driving investor confidence and the stock's upward movement.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TDOC","symbol_name":"Teladoc Health Inc.","start_time":0,"source_url":"","article_id":"1148412481","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1148412481","pubTimestamp":1761314918,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Teladoc Health Inc. (TDOC) shares are soaring 5.12% in pre-market trading on Friday, following the company's announcement of better-than-expected preliminary third-quarter revenue and reaffirmed...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TDOC":"Teladoc Health Inc."},"translate_title":"股票追踪|Teladoc Health因第三季度收入超出预期和积极的分析师前景而飙升5.12%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TDOC":1},"content_text":"Teladoc Health Inc. (TDOC) shares are soaring 5.12% in pre-market trading on Friday, following the company's announcement of better-than-expected preliminary third-quarter revenue and reaffirmed full-year guidance. The telehealth provider reported preliminary Q3 revenue of $626.4 million, surpassing analysts' estimates of $625.9 million.\nDespite the announced departure of Chief Financial Officer Mala Murthy, effective November 21, investors seem to be focusing on the company's strong financial performance. Teladoc also reiterated its 2025 revenue forecast range of $2.50 billion to $2.55 billion, in line with analyst expectations of $2.52 billion.\nThe positive sentiment is further bolstered by analyst actions. Bank of America raised its price target on Teladoc to $9 from $8.50, while maintaining a Neutral rating. Canaccord Genuity analyst Richard Close reiterated a Buy rating with a $12 price target, citing the company's potential for growth. These developments suggest that despite leadership changes, Teladoc's business fundamentals remain strong, driving investor confidence and the stock's upward movement.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}